AXNX — Axonics Share News
0.000.00%
Last trade - 00:00HealthcareAdventurousLarge Cap
- $3.63bn
- $3.28bn
- $366.38m
Brief: Axonics posts Q1 EPS of USD -0.19
Axonics Inc expected to post a loss of 29 cents a share - Earnings Preview
Brief: Axonics Acquires Tech For Better Placement Of Implantable Leads For Sacral Neuromodulation
U.S. RESEARCH ROUNDUP- Axonics, Chipotle Mexican Grill, ResMed
U.S. RESEARCH ROUNDUP-Amazon.com, Dell, Unum Group, Penumbra
U.S. RESEARCH ROUNDUP-Amazon.Com, Unum Group, Penumbra
Axonics Inc reports results for the quarter ended in December - Earnings Summary
Brief: Axonics Reports Fourth Quarter And Fiscal Year 2022 Financial Results
Brief: Axonics Q4 revenue USD 85.918 million
U.S. STOCKS ON THE MOVE-Ionis, PulteGroup, Atlas Technical, Tesla
U.S. STOCKS ON THE MOVE-A O Smith, Pentair, health insurers
Axonics rises on FDA nod for incontinence treatment device
Brief: Axonics Receives FDA Approval For Fourth-Generation Rechargeable Sacral Neuromodulation System
Axonics rises as prelim Q4 revenue beats expectations
Brief: Axonics Sees Q4 2022 Revenue $85.6 Million To $86.0 Million
Brief: Axonics Receives Health Canada Approval For Fourth-Generation Rechargeable Sacral Neuromodulation System
U.S. RESEARCH ROUNDUP-Carvana, Centerspace, Lennox International
Brief: Axonics® Reports Third Quarter 2022 Financial Results
Axonics Inc reports results for the quarter ended in September - Earnings Summary